Article
Therapeutic Targeting of DNA Damage Response in Cancer
1 Feb 2022
Abstract excerpt
DNA damage response (DDR) is critical to ensure genome stability, and defects in this signaling pathway are highly associated with carcinogenesis and tumor progression. Nevertheless, this also provides therapeutic opportunities, as cells with defective DDR signaling are directed to rely on compensatory survival pathways, and these vulnerabilities have been exploited for anticancer treatments. Following the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
